Medicine: Pills for Diabetes

For as long as 2½ years, hundreds of thousands of diabetics all over the world have been treated with tablets of tolbutamide instead of insulin injections. Many have rejoiced at their new-found freedom from the need for daily needlework. Last week the Upjohn Co. (which markets the drug as Orinase) decided to lay on the line just what it will and will not do. To its Kalamazoo headquarters Upjohn invited 500 physicians to hear reports from Germany's Dr. Ernst Pfeiffer, one of the first investigators to use the drug, and from Chicago's Dr. Rachmiel...

Want the full story?

Subscribe Now


Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!